Skip to content

Clinical trials

Completed Phase 1/2 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Completed Country / region: Hong Kong Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20052
20061
20072
20085
20092
20104
20111
20122
20132
20143
20151
20163
20172
20185
20201
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Chinese University of Hong Kong5
Puma Biotechnology, Inc.4
The Hong Kong Polytechnic University3
BioAtla, Inc.2
Bristol-Myers Squibb2
Pfizer2
Vir Biotechnology, Inc.2
AVEO Pharmaceuticals, Inc.1
Alachua Government Services, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung7
Neoplasms7
Breast Neoplasms6
Carcinoma, Hepatocellular6
Carcinoma3
Hepatitis B3
Hepatitis B, Chronic3
Liver Neoplasms3
Melanoma3
Cholangiocarcinoma2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.